Sunesis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
Sunesis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
Summary
Sunesis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Key Highlights
Sunesis Pharmaceuticals, Inc (Sunesis or 'the company') develops and commercializes oncology therapeutics for the treatment of hematologic and solid cancers. The company's major products include Vosaroxin, TAK-580, SSN-510 and Vecabrutinib. The company has collaboration agreement with Biogen Idec MA, Inc. to discover, develop and commercialize small molecule inhibitors of the human protein Raf kinase and with Takeda Pharmaceutical Company Limited to develop and commercialize preclinical inhibitors of PDK1 and TAK-580. Sunesis conducts various clinical trials and analysis for developing products that identifies and implements alternative methods for treating cancer and also obtain licenses for developing various critical products. The company is headquartered in South San Francisco, California, the US.
Scope
Summary
Sunesis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Key Highlights
Sunesis Pharmaceuticals, Inc (Sunesis or 'the company') develops and commercializes oncology therapeutics for the treatment of hematologic and solid cancers. The company's major products include Vosaroxin, TAK-580, SSN-510 and Vecabrutinib. The company has collaboration agreement with Biogen Idec MA, Inc. to discover, develop and commercialize small molecule inhibitors of the human protein Raf kinase and with Takeda Pharmaceutical Company Limited to develop and commercialize preclinical inhibitors of PDK1 and TAK-580. Sunesis conducts various clinical trials and analysis for developing products that identifies and implements alternative methods for treating cancer and also obtain licenses for developing various critical products. The company is headquartered in South San Francisco, California, the US.
Scope
- Detailed information on Sunesis Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sunesis Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Sunesis Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Sunesis Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sunesis Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
- Gain understanding of Sunesis Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Sunesis Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Sunesis Pharmaceuticals, Inc.'s business structure, strategy and prospects.
Table of Contents
Company Snapshot
Sunesis Pharmaceuticals, Inc.: Company Overview
Sunesis Pharmaceuticals, Inc.: Overview and Key Facts
Sunesis Pharmaceuticals, Inc.: Overview
Sunesis Pharmaceuticals, Inc.: Key Facts
Sunesis Pharmaceuticals, Inc.: Key Employees
Sunesis Pharmaceuticals, Inc.: Key Employee Biographies
Sunesis Pharmaceuticals, Inc.: Major Products and Services
Sunesis Pharmaceuticals, Inc.: Company History
Sunesis Pharmaceuticals, Inc.: Management Statement
Sunesis Pharmaceuticals, Inc.: Locations and Subsidiaries
Sunesis Pharmaceuticals, Inc.: Key Competitors
Sunesis Pharmaceuticals, Inc.: Company Analysis
Sunesis Pharmaceuticals, Inc.: Business Description
Sunesis Pharmaceuticals, Inc.: SWOT Analysis
Sunesis Pharmaceuticals, Inc.: SWOT Overview
Sunesis Pharmaceuticals, Inc.: Strengths
Sunesis Pharmaceuticals, Inc.: Weaknesses
Sunesis Pharmaceuticals, Inc.: Opportunities
Sunesis Pharmaceuticals, Inc.: Threats
Sunesis Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Sunesis Pharmaceuticals, Inc.: Financial Deals Overview
Sunesis Pharmaceuticals, Inc.: Targets and Partners
Sunesis Pharmaceuticals, Inc.: Top Deals 2016 - 2020YTD*
Sunesis Pharmaceuticals, Inc.: Advisors
Sunesis Pharmaceuticals, Inc.: Top Legal Advisors
Sunesis Pharmaceuticals, Inc.: Top Financial Advisors
Sunesis Pharmaceuticals, Inc.: Capital Raising
Sunesis Pharmaceuticals, Inc.: Partnership
Sunesis Pharmaceuticals, Inc.: Recent Developments
Sunesis Pharmaceuticals, Inc.: News and Events Summary
Sunesis Pharmaceuticals, Inc.: Corporate Governance
Sunesis Pharmaceuticals, Inc.: Financial Performance
Sunesis Pharmaceuticals, Inc.: Regulatory and Legal Events
Sunesis Pharmaceuticals, Inc.: Research & Development
Appendix
Contact Us
Methodology
About MarketLine
Company Snapshot
Sunesis Pharmaceuticals, Inc.: Company Overview
Sunesis Pharmaceuticals, Inc.: Overview and Key Facts
Sunesis Pharmaceuticals, Inc.: Overview
Sunesis Pharmaceuticals, Inc.: Key Facts
Sunesis Pharmaceuticals, Inc.: Key Employees
Sunesis Pharmaceuticals, Inc.: Key Employee Biographies
Sunesis Pharmaceuticals, Inc.: Major Products and Services
Sunesis Pharmaceuticals, Inc.: Company History
Sunesis Pharmaceuticals, Inc.: Management Statement
Sunesis Pharmaceuticals, Inc.: Locations and Subsidiaries
Sunesis Pharmaceuticals, Inc.: Key Competitors
Sunesis Pharmaceuticals, Inc.: Company Analysis
Sunesis Pharmaceuticals, Inc.: Business Description
Sunesis Pharmaceuticals, Inc.: SWOT Analysis
Sunesis Pharmaceuticals, Inc.: SWOT Overview
Sunesis Pharmaceuticals, Inc.: Strengths
Sunesis Pharmaceuticals, Inc.: Weaknesses
Sunesis Pharmaceuticals, Inc.: Opportunities
Sunesis Pharmaceuticals, Inc.: Threats
Sunesis Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Sunesis Pharmaceuticals, Inc.: Financial Deals Overview
Sunesis Pharmaceuticals, Inc.: Targets and Partners
Sunesis Pharmaceuticals, Inc.: Top Deals 2016 - 2020YTD*
Sunesis Pharmaceuticals, Inc.: Advisors
Sunesis Pharmaceuticals, Inc.: Top Legal Advisors
Sunesis Pharmaceuticals, Inc.: Top Financial Advisors
Sunesis Pharmaceuticals, Inc.: Capital Raising
Sunesis Pharmaceuticals, Inc.: Partnership
Sunesis Pharmaceuticals, Inc.: Recent Developments
Sunesis Pharmaceuticals, Inc.: News and Events Summary
Sunesis Pharmaceuticals, Inc.: Corporate Governance
Sunesis Pharmaceuticals, Inc.: Financial Performance
Sunesis Pharmaceuticals, Inc.: Regulatory and Legal Events
Sunesis Pharmaceuticals, Inc.: Research & Development
Appendix
Contact Us
Methodology
About MarketLine
LIST OF TABLES
Table 1: Sunesis Pharmaceuticals, Inc.: Key Facts
Table 2: Sunesis Pharmaceuticals, Inc.: Key Employees
Table 3: Sunesis Pharmaceuticals, Inc.: Company History
Table 4: Sunesis Pharmaceuticals, Inc.: Locations and Subsidiaries
Table 5: Sunesis Pharmaceuticals, Inc.: Key Competitors
Table 6: Sunesis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Sunesis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Sunesis Pharmaceuticals, Inc.: Targets and Partners
Table 9: Sunesis Pharmaceuticals, Inc.: Top Deals 2016 - 2020YTD*
Table 10: Sunesis Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Sunesis Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Sunesis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 13: Sunesis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2016 - YTD*2020)
Table 14: Sunesis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 15: Sunesis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 16: Sunesis Pharmaceuticals, Inc.: News and Events Summary
Table 17: Sunesis Pharmaceuticals, Inc.: Corporate Governance
Table 18: Sunesis Pharmaceuticals, Inc.: Financial Performance
Table 19: Sunesis Pharmaceuticals, Inc.: Regulatory and Legal Events
Table 20: Sunesis Pharmaceuticals, Inc.: Research & Development
Table 1: Sunesis Pharmaceuticals, Inc.: Key Facts
Table 2: Sunesis Pharmaceuticals, Inc.: Key Employees
Table 3: Sunesis Pharmaceuticals, Inc.: Company History
Table 4: Sunesis Pharmaceuticals, Inc.: Locations and Subsidiaries
Table 5: Sunesis Pharmaceuticals, Inc.: Key Competitors
Table 6: Sunesis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Sunesis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Sunesis Pharmaceuticals, Inc.: Targets and Partners
Table 9: Sunesis Pharmaceuticals, Inc.: Top Deals 2016 - 2020YTD*
Table 10: Sunesis Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Sunesis Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Sunesis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 13: Sunesis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2016 - YTD*2020)
Table 14: Sunesis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 15: Sunesis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 16: Sunesis Pharmaceuticals, Inc.: News and Events Summary
Table 17: Sunesis Pharmaceuticals, Inc.: Corporate Governance
Table 18: Sunesis Pharmaceuticals, Inc.: Financial Performance
Table 19: Sunesis Pharmaceuticals, Inc.: Regulatory and Legal Events
Table 20: Sunesis Pharmaceuticals, Inc.: Research & Development
LIST OF FIGURES
Figure 1: Sunesis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Sunesis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Figure 3: Sunesis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Figure 4: Sunesis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2016 - YTD*2020)
Figure 5: Sunesis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2016 - YTD*2020)
Figure 6: Sunesis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2016 - YTD*2020)
Figure 1: Sunesis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Sunesis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Figure 3: Sunesis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Figure 4: Sunesis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2016 - YTD*2020)
Figure 5: Sunesis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2016 - YTD*2020)
Figure 6: Sunesis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2016 - YTD*2020)
